NBQX (2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline) is an antagonist of the AMPA receptor. NBQX blocks AMPA receptors in micromolar concentrations (~10–20 μM) and also blocks …

NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. NBQX has neuroprotective and anticonvulsant activity.

2023年2月26日 · NBQX是一种AMPA 结合位点的有效且有鉴别力的 拮抗剂 。 该化合物具有神经保护特性。 图1.NBQX化学结构. NBQX基础信息. 中文名：AMPA拮抗剂；红藻氨酸拮抗剂； …

We found that only NBQX had an effect on acute seizure development, resulting in a significantly higher number of mice experiencing seizures, an increase in the number of seizures per …

NBQX is a compound that shows a 30-fold greater affinity for AMPA binding compared to kainate binding, and is essentially inactive at the glycine site of the NMDA receptor. You might find …

NBQX (FG9202) 是一种 AMPA 受体拮抗剂。 CAS号 (CAS NO.) 1. 为了您的安全和健康，请穿实验服并戴一次性手套操作。 2. 粉末溶解前请先短暂离心，以保证产品全在管底。 3. 避光干燥 …

NBQX (FG9202) has a high affinity for AMPA and kainate binding sites with little or no affinity for the glutamate recognition site on the NMDA receptor complex.

NBQX (2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F) quinoxaline) is an analogue of the quinoxalinedione antagonists to the non-NMDA glutamate receptor. NBQX is a potent and …

To determine whether AMPA receptor (AMPAR) antagonist NBQX can prevent early mTOR pathway activation and long-term sequelae following neonatal seizures in rats, including later …